Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5960637 | 0.80 | ALDH1A1 (0.39) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL2152882 | 0.80 | TSHR (0.34) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL8007543 | 0.74 | — | — | |
| SCHEMBL12733084 | 0.73 | ALDH1A1 (0.40) | TSHRNPSR1KDM4EHSD17B10MEN1 | |
| SCHEMBL569197 | 0.72 | TSHR (0.35) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL13108981 | 0.72 | TSHR (0.35) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL2152884 | 0.71 | TSHR (0.30) | TSHRNPSR1 | |
| SCHEMBL28481264 | 0.70 | TSHR (0.34) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL14530109 | 0.70 | TSHR (0.34) | TSHRNPSR1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL9402444 | 0.68 | DGAT1 (0.34) | MEN1LMNAMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9452987-B2 | Five-membered cyclic anion use thereof as an electrolyte | CENTRE NAT RECH SCIENT (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20150315155-A1 | FIVE-MEMBERED CYCLIC ANION USE THEREOF AS AN ELECTROLYTE | CENTRE NAT RECH SCIENT (FR) | 2015-11-05 | — | — | US | disclosed |
| US-8927160-B2 | Pentacyclic anion salt and use thereof as an electrolyte | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-01-06 | — | — | US | disclosed |
| US-20110311884-A1 | PENTACYCLIC ANION SALT AND USE THEREOF AS AN ELECTROLYTE | UNIVERSITE DE PICARDIE JULES VERNE (FR) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110311884-A1 | PENTACYCLIC ANION SALT AND USE THEREOF AS AN ELECTROLYTE | AFF1, SLCO4C1, F9 | TSHR 1923/4885NPSR1 1329/4885KDM4E 3600/4885 |
| US-20150315155-A1 | FIVE-MEMBERED CYCLIC ANION USE THEREOF AS AN ELECTROLYTE | KCNA5, SLCO4C1, AFF1 | TSHR 2779/4885NPSR1 2201/4885KDM4E 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.